Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug…
Forschung, die ankommt: FWF-Projekte schaffen Impulse für Wirtschaft und Gesellschaft
2024 finanzierte der FWF 683 neue Projekte mit 408 Mio. €. Über 5.000 Personen forschen mit FWF-Mitteln an Österreichs…
Biomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase
The company, a leading manufacturer of recombinant proteins, announced the commercial availability of its CRISPR/Cas9…
BOKU Wien: Ein metabolischer Leitfaden fürs Leben im All
Hefe und Pilze könnten der Schlüssel zum langfristigen Überleben im Weltraum sein. Wie, das zeigt das multidisziplinäre…
MedUni Vienna: Important step towards improving diagnosis and treatment of brain metastases
Brain metastases often occur as a result of advanced cancer and, despite medical innovations, are still associated with…
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines…
ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets
ViVerita Therapeutics ("ViVerita"), a US-based next-generation precision oncology company, today announced a strategic…
Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates
- Total revenues of €49.2 million compared to €32.8 million in the first quarter of 2024
- Cash and cash equivalents of…
AGES entwickelt und testet mobiles Hochsicherheitslabor
EU-weites One-Health-Projekt MOBILISE entwickelt mobiles Labor, in dem Proben von Menschen, Tieren und der Umwelt…
MedUni Vienna: Diabetes drug as a possible treatment for prostate cancer
An international team of scientists led by the Medical University of Vienna has identified similarities in the…
AGES develops and tests mobile high-security laboratory
A truck on the outside, a state-of-the-art laboratory on the inside: we develop and test the possible uses of a mobile…
Ribbon Bio Launches MiroSynth™ DNA Molecules to Unlock a New Era of Complex Synthetic DNA
First Commercial Offering Delivers Complex, Long, and Highly Accurate DNA to Power Transformative Scientific…